Bleomycin for Head and Neck Venolymphatic Malformations: A Systematic Review

Keyphrases

• Benign Vascular Lesion 20%
• Bleomycin 100%
• Cochrane Library 20%
• Data Synthesis 20%
• Effective Treatment 20%
• Embase 20%
• Extracted Data 20%
• First-line Therapy 20%
• Head-and-neck 100%
• Highly Effective 20%
• Inclusion Criteria 20%
• Lesion Size 40%
• Library Databases 20%
• Low Dose Rate 20%
• Low-to-moderate 20%
• Lymphatic Malformation 100%
• Major Adverse Events 20%
• Major Complications 40%
• Minor Complications 40%
• Objective Reduction 20%
• Pingyangmycin 20%
• PubMed 20%
• Risk of Bias 20%
• Sclerosing Agent 20%
• Sclerotherapy 60%
• Size Reduction 20%
• Systematic Literature Review 20%

Medicine and Dentistry

• Adverse Event 20%
• Bleomycin 100%
• Bleomycin A5 20%
• Congenital Malformation 100%
• Neck 100%
• Sclerosing Agent 20%
• Sclerotherapy 60%
• Systematic Review 100%
• Vascular Lesion 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Event 20%
• Bleomycin 100%
• Bleomycin A5 20%
• Congenital Malformation 100%
• Sclerosing Agent 20%
• Vascular Lesion 20%